CA2357403A1 - Vecteur codant pour pax et son utilisation - Google Patents

Vecteur codant pour pax et son utilisation Download PDF

Info

Publication number
CA2357403A1
CA2357403A1 CA 2357403 CA2357403A CA2357403A1 CA 2357403 A1 CA2357403 A1 CA 2357403A1 CA 2357403 CA2357403 CA 2357403 CA 2357403 A CA2357403 A CA 2357403A CA 2357403 A1 CA2357403 A1 CA 2357403A1
Authority
CA
Canada
Prior art keywords
cells
muscle
pax7
pax
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2357403
Other languages
English (en)
Inventor
Michael A. Rudnicki
Patrick Seale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ottawa Health Research Institute
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2357403 priority Critical patent/CA2357403A1/fr
Publication of CA2357403A1 publication Critical patent/CA2357403A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA 2357403 2001-09-14 2001-09-14 Vecteur codant pour pax et son utilisation Abandoned CA2357403A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2357403 CA2357403A1 (fr) 2001-09-14 2001-09-14 Vecteur codant pour pax et son utilisation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2357403 CA2357403A1 (fr) 2001-09-14 2001-09-14 Vecteur codant pour pax et son utilisation

Publications (1)

Publication Number Publication Date
CA2357403A1 true CA2357403A1 (fr) 2003-03-14

Family

ID=4169995

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2357403 Abandoned CA2357403A1 (fr) 2001-09-14 2001-09-14 Vecteur codant pour pax et son utilisation

Country Status (1)

Country Link
CA (1) CA2357403A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005105996A1 (fr) * 2004-04-30 2005-11-10 Ottawa Health Research Institute Vecteur de codage pax et utilisation associee

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384784B2 (en) 2001-09-17 2008-06-10 Ottawa Health Research Institute Pax-encoding vector and use thereof
WO2005105996A1 (fr) * 2004-04-30 2005-11-10 Ottawa Health Research Institute Vecteur de codage pax et utilisation associee

Similar Documents

Publication Publication Date Title
JP6539188B2 (ja) 多能性胚様幹細胞、その組成物、方法および使用
Chang et al. Generation of transplantable, functional satellite‐like cells from mouse embryonic stem cells
JP4371179B2 (ja) 系列限定ニューロン前駆体
US20060003312A1 (en) Circulating stem cells and uses related thereto
CN106163572B (zh) 用于诱导体细胞直接转分化为血管祖细胞的组合物及其用途
JP2003523767A (ja) 脂肪組織由来の間質細胞から生成した多能性幹細胞およびその用途
AU2002337949B1 (en) Stem cells that transform to beating cardiomyocytes
US8679833B2 (en) Stem cells, nucleotide sequences and proteins therefrom
WO2010056341A2 (fr) Compositions et procédés pour la réparation tissulaire
CA2883922A1 (fr) Procede de proliferation de cellules souches par le biais de l'activation de la signalisation des c-met/hgf et de la signalisation notch
Law et al. Myoblast transfer therapy for Duchenne muscular dystrophy
CN110291190B (zh) 骨骼肌细胞及其诱导方法
KR20010021499A (ko) 계통이 예정된 신경세포 전구체
WO2005105996A1 (fr) Vecteur de codage pax et utilisation associee
US7297538B2 (en) Encapsulated cell indicator system
WO2003095631A1 (fr) Methode de mise en place et de developpement de cellules souches multipotentes
US8895303B2 (en) Method of cell culture and method of treatment comprising a vEPO protein variant
WO2015133792A1 (fr) Composition pour induire la transdifférenciation directe de cellules somatiques en cellules progénitrices vasculaires, et son utilisation
WO2006017567A2 (fr) Adaptation de cardiomyocytes derives de cellules souches pour transplantation
KR101269124B1 (ko) ｃ－ＭＥＴ／ＨＧＦ 신호 활성을 이용한 줄기세포의 증식 방법
US20040120933A9 (en) Pax-encoding vector and use thereof
KR101269125B1 (ko) 노치 신호 활성 유전자를 이용한 줄기세포의 증식 방법
CA2357403A1 (fr) Vecteur codant pour pax et son utilisation
Pruller et al. Overview of Cell Types Capable of Contributing to Skeletal Muscle Repair and Regeneration
TWI769410B (zh) 新穎誘導性多能幹細胞(ipscs)及其應用

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead